Catalonia has moved up to fourth place in Europe for clinical trials, according to the Generalitat, strengthening its position as a health and life sciences research hub. The region now ranks behind Germany, France and the United Kingdom, and ahead of countries including Switzerland, Sweden and Denmark.
Data from the Ministry of Health shows Catalonia rose from sixth place in the previous year. The improvement is linked to a higher number of clinical trials carried out across the region.
Health Minister Manel Balcells said the result reflects the joint effort of healthcare professionals, pharmaceutical companies and public administrations. He said the progress shows Catalonia's capacity for innovation and excellence in biomedical research.
The government says it will continue to support health research and innovation, with new measures aimed at attracting talent and increasing investment in scientific infrastructure. For more Catalonia-wide updates, see News.
Gemma Rius, director of the Catalan Council for Research and Innovation, said the European ranking is a key indicator of the quality and competitiveness of Catalonia's research system. She said the fourth-place result positions Catalonia as a benchmark in Europe for clinical trials and could help attract international projects.
Most clinical trials are still concentrated in Barcelona, but Girona is increasing its presence in health and life sciences research. The sector remains centred on the metropolitan area, although it is expanding beyond it.
